IL34 and metabolic dysfunction-associated steatotic liver disease: A novel diagnostic marker IL34-FS, which includes the factors of serum IL-34, type IV collagen 7s and age, could be feasible for the diagnosis of liver fibrosis in patients with NAFLD.